drugset / Trial / NCT00783237

Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)

NCT00783237

Phase 4 Completed 340 enrolled Organon and Co
RandomizedParallel-groupTriple-blindTreatment

Summary

This was a single-dose study to determine the time it takes for mometasone furoate nasal spray to go in effect, after a single dose of 2 sprays per nostril. Patients who are eligible were exposed to ragweed pollen for 3 hours on one or two occasions. Patients who experienced adequate symptoms during the pollen exposure phase came back for a Treatment Phase visit. During the Treatment Phase visit, patients were exposed to ragweed pollen for 2 hours and then received either mometasone or placebo nasal spray. Symptom evaluations began on the patients every hour for the next 11 hours.

Timeline

Start
2003-12-01
Primary completion
2004-02-21
Completion
2004-02-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone Other / unclassified 200 ug Intranasal

Indications